New York State Common Retirement Fund
INDV icon

New York State Common Retirement Fund’s Indivior Pharmaceuticals INDV Stock Holding History

New York State Common Retirement Fund’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Buy
42,200
+3,800
+10% +$138K ﹤0.01% 1519
2026
Q1 		$1.17M Hold
38,400
– – ﹤0.01% 1605
2025
Q4 		$1.38M Hold
38,400
– – ﹤0.01% 1569
2025
Q3 		$926K Sell
38,400
-56,140
-59% -$1.17M ﹤0.01% 1717
2025
Q2 		$1.39M Buy
94,540
+63,580
+205% +$740K ﹤0.01% 1538
2025
Q1 		$295K Buy
+30,960
New +$325K ﹤0.01% 2073
2024
Q2 		– Sell
-659
Closed -$14.1K – 3411
2024
Q1 		$14.1K Hold
659
– – ﹤0.01% 3172
2023
Q4 		$10.1K Hold
659
– – ﹤0.01% 3193
2023
Q3 		$14.5K Hold
659
– – ﹤0.01% 3203
2023
Q2 		$15.4K Buy
+659
New +$15.1K ﹤0.01% 3247

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York State Common Retirement Fund's INDV Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Indivior Pharmaceuticals (INDV) stake by 9.9% in Q2 2026, buying an estimated $138K and bringing the position to 42,200 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

New York State Common Retirement Fund first reported a position in INDV in Q2 2023 and has held it in 10 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • New York State Common Retirement Fund held 42,200 shares of Indivior Pharmaceuticals worth $1.73M as of Q2 2026.
  • New York State Common Retirement Fund bought 3,800 Indivior Pharmaceuticals shares in Q2 2026, an estimated $138K.
  • Indivior Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1519 holding.
  • New York State Common Retirement Fund first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 10 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.